The companies have previously told the court that their COVID vaccine Comirnaty does not work in the same way as CureVac's patented technology. District Court in Massachusetts, seeking a judgment that they did not infringe U.S. Pfizer and BioNTech in response had filed a complaint with the U.S. If you continue using our website, well assume that you are happy to receive all cookies on this website.
We use them to give you the best experience. Pfizer and BioNTech did not immediately respond to requests for comment. TransData’s Smart Electric Meter Patents cover pioneering technology invented by TransData that enables equipping a digital electric meter with an internal.
Transdata patent lawsuit trial#
Bulletproof TransData patents get trial date in GE patent infringement dispute. The transfer of the trial to the Eastern District of Virginia from the Federal District Court of Massachusetts is expected to accelerate progress of the case and allow for a likely 2024 trial date, CureVac said on Friday. TransData Inc.s primary competitors include ClearStory Data, DataHero. TransData is a developer and manufacturer of digital electricity meters and other energy measurement products and, on September 16, the company announced that it has filed patent infringement lawsuits against GE, Itron and Landis+Gyr AG (60 percent owned. In July 2022, CureVac had filed a patent lawsuit against BioNTech over the use of mRNA technology in the companies' COVID-19 vaccine. ITRI has reached an agreement to settle patent litigation claims brought by TransData, Inc. CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc and BioNTech over the use of mRNA technology and that a U.S. The company said it filed a counterclaim alleging that Pfizer and its German partner BioNTech infringed on nine of its patents, broader than its original claim of three patents. court had granted its request to transfer the trial. May 19 (Reuters) - CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc (PFE.N) and BioNTech over the use of mRNA technology and that a U.S.
0 kommentar(er)
